Condition
Neonatal Opioid Withdrawal
Total Trials
4
Recruiting
0
Active
0
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 5/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.4% vs benchmark
Late-Stage Pipeline
50%
2 trials in Phase 3/4
Results Transparency
67%
2 of 3 completed with results
Key Signals
2 with results100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (2)
P 3 (1)
P 4 (1)
Trial Status
Completed3
Not Yet Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.6%
Based on 3 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT07610746Not ApplicableNot Yet RecruitingPrimary
Cerebral Physiology of NOWS
NCT05746507Not ApplicableCompleted
Night Respite for Postpartum Mothers With SUD
NCT04298853Phase 4Completed
Optimal Morphine Dosing Schedule for Neonatal Abstinence Syndrome
NCT01958476Phase 3Completed
Improving Outcomes in Neonatal Abstinence Syndrome
Showing all 4 trials